1.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000499633, NCCTG-N0574, ACOSOG-N0574, N0574, NCT00377156
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0976, NCT01202851
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000706698, ANZGOG-0902-GOG-0274/RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MIND, NCT01700959
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: A221101, N10C3, NCI-2012-02020, NCT01781468
|
|
6.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: OHSU-2868, P30CA069533, 8507, SOL-04058-L, 2868, OHSU-8507, OHSU-SOL-04058-L, NCT00303849
|
|
7.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HCI55264, NCT01580969
|
|
8.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 88 Sponsor: NCI, Other Protocol IDs: 31416, NCT01238120
|
|
9.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006-0022, NCT01283997
|
|
10.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: NEU-SIUSOM-11-002, NCT01374191
|
|
11.
|
Phase: Phase II Type: Supportive care Status: Active Age: 6 to 17 Sponsor: NCI, Other Protocol IDs: SCUSF 0901, ACCL0922, 5U10CA081920-11, NCT01381718
|
|
12.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: RTOG 1114, CDR0000703682, NCT01399372
|
|
13.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: STU 042011-050, NCT01414738
|
|
14.
|
Phase: Phase II Type: Supportive care Status: Active Age: 21 to 65 Sponsor: Other Protocol IDs: 11-003446, JCCCID256, NCT01540955
|
|
15.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 3 to 21 Sponsor: NCI, Other Protocol IDs: ACNS1123, NCI-2012-01967, CDR0000734032, U10CA098543, COG-ACNS1123, NCT01602666
|
|
16.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H-27747, NCT01614990
|
|
17.
|
Phase: Phase I Type: Supportive care Status: Active Age: 18 to 45 Sponsor: Other Protocol IDs: 05-08-069-01, NCT00352599
|
|
18.
|
Phase: Phase I Type: Natural history/Epidemiology, Supportive care Status: Active Age: 40 to 75 Sponsor: Other Protocol IDs: BRS0002, SU-04062009-2139, 14623, SUMC-14623, NCT00866931, NCT00896324
|
|
19.
|
Phase: Phase I Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CCCWFU 97409, NCI-2009-01452, NCT01151670
|
|
20.
|
Phase: Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SRS-Cavity-01, NCT01395407
|
|
21.
|
Phase: Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Pro00031192, NCT01639612
|
|
22.
|
Phase: Phase I Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: IRB/COSA # 079-12, NCT01682499
|
|
23.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 to 80 Sponsor: Other Protocol IDs: Pro00025906, NCT01725633
|
|
24.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 1 to 17 Sponsor: NCI, Other Protocol IDs: CDR0000528920, COG-AALL06N1, AALL06N1, NCT00437060
|
|
25.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 9 to 16 Sponsor: Other Protocol IDs: PEDSVAR0003, 97817, NCT00490334
|